O'Brien Greene & Co’s Omnicell OMCL Stock Holding History

O'Brien Greene & Co’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,100	Closed	-$374K	–	114
2018 Q4	$374K	Buy	+6,100	New	+$413K	0.22%	78

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

O'Brien Greene & Co's OMCL Position: Q1 2019 in Review

O'Brien Greene & Co sold out of Omnicell (OMCL) in Q1 2019, closing a stake of 6,100 shares — an estimated $374K sold.

O'Brien Greene & Co first reported a position in OMCL in Q4 2018 and held it in 1 quarter. The position peaked at $374K in Q4 2018. 306 funds tracked by Wall St. Rank hold OMCL as of Q1 2019.

O'Brien Greene & Co reported no remaining Omnicell position as of Q1 2019 after selling out during the quarter.
O'Brien Greene & Co sold 6,100 Omnicell shares in Q1 2019, an estimated $374K.
O'Brien Greene & Co first reported a position in Omnicell in Q4 2018 and held it in 1 quarter.
O'Brien Greene & Co's Omnicell position peaked at $374K in Q4 2018.
306 funds tracked by Wall St. Rank held Omnicell as of Q1 2019.

Based on O'Brien Greene & Co's 13F filing for Q1 2019, filed 29 Apr 2019.